Sleep Medicine News

CHARLOTTE, N.C. — The link between sleep apnea and cardiovascular disease involves multiple pathways and outcomes, Susan Redline, MD, MPH, Peter C. Farrell Professor of Sleep Medicine at Harvard Medical School, said at SLEEP 2022.

Pediatric melatonin consumption in the United States has risen more than fivefold since 2012, with related hospitalization increasing as well, according to data published Thursday in MMWR.

Patients with CVD are 40% to 80% more likely to have comorbid obstructive sleep apnea, which in severe cases can cause them to stop breathing hundreds of times a night.

Digital therapeutics company Big Health has announced a partnership with the University of Oxford for a new study evaluating Sleepio, an online program designed to improve sleep and mental health for stroke patients.

SEATTLE — Abnormalities during sleep may be associated with neurological conditions, Alberto Ramos, MD, a sleep disorder specialist at the University of Miami, said at the 2022 American Academy of Neurology annual meeting.

Researchers identified significant U-shaped associations between sleep duration and cardiovascular mortality, 10-year atherosclerotic CVD risk and C-reactive protein, a marker of inflammation.

In this week's edition, the FDA approval of a transdermal patch to treat Alzheimer’s-related dementia; the link between daily napping and an increased risk for Alzheimer’s disease; an oral treatment for Parkinson’s; and more.

A week of physical inactivity has the same negative mental impact as a week of broken sleep, a study by sports equipment company Asics revealed.

Natalia S. Rost, MD, MPH, chair of the AAN science committee, led a discussion to highlight select studies being presented at the AAN’s annual meeting April 2-7 in Seattle.

Older adults who nap for more than an hour a day had a 40% higher risk for developing Alzheimer’s disease compared with those who napped less than an hour a day, researchers reported in Alzheimer’s & Dementia.